REVIEW 1 cited by
A structured regression approach for evaluating model performance across intersectional subgroups
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Disaggregated evaluation is a central task in AI fairness assessment, where the goal is to measure an AI system's performance across different subgroups defined by combinations of demographic or other sensitive attributes. The standard approach is to stratify the evaluation data across subgroups and compute performance metrics separately for each group. However, even for moderately-sized evaluation datasets, sample sizes quickly get small once considering intersectional subgroups, which greatly limits the extent to which intersectional groups are included in analysis. In this work, we introduce a structured regression approach to disaggregated evaluation that we demonstrate can yield reliable system performance estimates even for very small subgroups. We provide corresponding inference strategies for constructing confidence intervals and explore how goodness-of-fit testing can yield insight into the structure of fairness-related harms experienced by intersectional groups. We evaluate our approach on two publicly available datasets, and several variants of semi-synthetic data. The results show that our method is considerably more accurate than the standard approach, especially for small subgroups, and demonstrate how goodness-of-fit testing helps identify the key factors that drive differences in performance.
Forward citations
Cited by 1 Pith paper
-
Critical Appraisal of Fairness Metrics in Clinical Predictive AI
A scoping review of 62 fairness metrics for clinical predictive AI finds a fragmented, threshold-dependent landscape with only one clinical utility metric.
Discussion (0). Sign in to comment.